EP3318248

TRANSLATE BIO, INC.
Application Number
EP17207662A
Filing Date
Nov 30, 2010
Status
Revoked
May 24, 2024
Grant Date
Apr 10, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3318248B1 was granted on Apr 10, 2019 by Translate Bio, Inc. The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRADY, PAUL ANDREWJan 10, 2020ADMISSIBLE
WITHERS & ROGERS LLPJan 10, 2020ADMISSIBLE

The table below shows the patents of Translate Bio, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2858679Pulmonary Delivery Of Mrna To Non-Lung Target CellsJun 5, 20241
EP3501605Mrna Therapy For Argininosuccinate Synthetase DeficiencyJun 28, 20231
EP2970456Methods And Compositions For Delivering Mrna Coded AntibodiesMay 19, 20214